Because of the overexpressed reactive oxygen species in the AD patients’ brains, this multifunctional nanocomposite can respond to HOCl rapidly, leading to the controlled release of fluorophore MB, and it acted as an effective inhibitor for inhibiting Tau protein aggregation, as proved by the ThT fluorescence test and circular dichroism test [56]. Here, MAPT is linked to Alzheimer disease.